 Joanna Arch
Concepts (241)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cancer Survivors | 14 | 2023 | 205 | 7.580 |
Why?
| | Acceptance and Commitment Therapy | 15 | 2023 | 27 | 7.480 |
Why?
| | Anxiety Disorders | 26 | 2023 | 303 | 5.910 |
Why?
| | Anxiety | 27 | 2023 | 840 | 5.230 |
Why?
| | Neoplasms | 14 | 2023 | 2097 | 3.270 |
Why?
| | Phobia, Social | 5 | 2023 | 13 | 2.890 |
Why?
| | Implosive Therapy | 6 | 2023 | 35 | 2.640 |
Why?
| | Advance Care Planning | 3 | 2023 | 197 | 1.910 |
Why?
| | Mindfulness | 4 | 2020 | 98 | 1.580 |
Why?
| | Stress, Psychological | 7 | 2020 | 944 | 1.520 |
Why?
| | Breast Neoplasms | 4 | 2023 | 1862 | 1.510 |
Why?
| | Self Concept | 3 | 2023 | 214 | 1.240 |
Why?
| | Adult | 46 | 2023 | 30544 | 1.120 |
Why?
| | Meditation | 3 | 2016 | 34 | 1.040 |
Why?
| | Quality of Life | 13 | 2023 | 2353 | 1.030 |
Why?
| | Humans | 73 | 2023 | 114662 | 0.950 |
Why?
| | Social Learning | 1 | 2023 | 5 | 0.880 |
Why?
| | Adaptation, Psychological | 7 | 2023 | 547 | 0.850 |
Why?
| | Survivors | 4 | 2023 | 411 | 0.770 |
Why?
| | Female | 48 | 2023 | 59493 | 0.770 |
Why?
| | Ovarian Neoplasms | 2 | 2023 | 388 | 0.760 |
Why?
| | Empathy | 3 | 2018 | 139 | 0.760 |
Why?
| | Hospice and Palliative Care Nursing | 1 | 2022 | 69 | 0.760 |
Why?
| | Depression | 7 | 2023 | 1134 | 0.720 |
Why?
| | Health Behavior | 3 | 2021 | 704 | 0.720 |
Why?
| | Anti-Anxiety Agents | 2 | 2013 | 42 | 0.710 |
Why?
| | Terminal Care | 1 | 2023 | 213 | 0.700 |
Why?
| | Safety | 2 | 2019 | 297 | 0.700 |
Why?
| | Young Adult | 18 | 2023 | 10466 | 0.690 |
Why?
| | Motivational Interviewing | 1 | 2021 | 88 | 0.690 |
Why?
| | Psycho-Oncology | 1 | 2019 | 3 | 0.650 |
Why?
| | Disease Susceptibility | 1 | 2021 | 316 | 0.650 |
Why?
| | Surveys and Questionnaires | 14 | 2021 | 4622 | 0.640 |
Why?
| | Avoidance Learning | 1 | 2019 | 63 | 0.620 |
Why?
| | Patient Acceptance of Health Care | 3 | 2021 | 681 | 0.600 |
Why?
| | Pregnancy Complications | 2 | 2012 | 429 | 0.600 |
Why?
| | Behavior Therapy | 3 | 2019 | 226 | 0.590 |
Why?
| | Salivary alpha-Amylases | 2 | 2016 | 2 | 0.590 |
Why?
| | Obsessive-Compulsive Disorder | 2 | 2015 | 32 | 0.590 |
Why?
| | Self-Help Groups | 1 | 2017 | 29 | 0.580 |
Why?
| | Attention | 5 | 2016 | 393 | 0.580 |
Why?
| | Chemotherapy, Adjuvant | 3 | 2023 | 332 | 0.570 |
Why?
| | Feasibility Studies | 5 | 2023 | 740 | 0.570 |
Why?
| | Fear | 5 | 2023 | 293 | 0.570 |
Why?
| | Heart Rate | 4 | 2014 | 709 | 0.570 |
Why?
| | Feedback, Psychological | 1 | 2017 | 20 | 0.560 |
Why?
| | Prejudice | 1 | 2017 | 55 | 0.550 |
Why?
| | Crowdsourcing | 1 | 2016 | 14 | 0.530 |
Why?
| | Patient Preference | 2 | 2017 | 167 | 0.530 |
Why?
| | Male | 37 | 2021 | 55583 | 0.520 |
Why?
| | Treatment Outcome | 18 | 2023 | 9088 | 0.520 |
Why?
| | Awareness | 3 | 2013 | 93 | 0.520 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2021 | 1183 | 0.500 |
Why?
| | Telemedicine | 1 | 2023 | 662 | 0.500 |
Why?
| | Auditory Perceptual Disorders | 1 | 2015 | 8 | 0.490 |
Why?
| | Stress Disorders, Traumatic | 1 | 2015 | 23 | 0.490 |
Why?
| | Hyperventilation | 3 | 2014 | 8 | 0.480 |
Why?
| | Emotions | 4 | 2017 | 472 | 0.480 |
Why?
| | Social Support | 2 | 2017 | 528 | 0.480 |
Why?
| | Middle Aged | 20 | 2023 | 26733 | 0.470 |
Why?
| | Psychotherapy | 2 | 2012 | 149 | 0.450 |
Why?
| | Medication Adherence | 3 | 2023 | 536 | 0.450 |
Why?
| | Alcohol Drinking | 2 | 2012 | 651 | 0.440 |
Why?
| | Data Collection | 1 | 2016 | 620 | 0.430 |
Why?
| | Women | 1 | 2013 | 51 | 0.430 |
Why?
| | Learning | 1 | 2017 | 350 | 0.430 |
Why?
| | Mind-Body Therapies | 1 | 2013 | 5 | 0.430 |
Why?
| | Pituitary-Adrenal System | 1 | 2014 | 130 | 0.420 |
Why?
| | Interinstitutional Relations | 1 | 2013 | 54 | 0.410 |
Why?
| | Hypothalamo-Hypophyseal System | 1 | 2014 | 164 | 0.410 |
Why?
| | Pilot Projects | 4 | 2023 | 1373 | 0.390 |
Why?
| | Relaxation | 2 | 2014 | 2 | 0.380 |
Why?
| | Feeding Behavior | 2 | 2016 | 574 | 0.380 |
Why?
| | Poly(ADP-ribose) Polymerase Inhibitors | 2 | 2023 | 68 | 0.380 |
Why?
| | Speech | 3 | 2023 | 68 | 0.370 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2022 | 1214 | 0.370 |
Why?
| | Biomedical Research | 2 | 2016 | 585 | 0.370 |
Why?
| | Fatigue | 2 | 2023 | 294 | 0.350 |
Why?
| | Aged | 10 | 2022 | 19069 | 0.350 |
Why?
| | Psychiatry | 1 | 2013 | 154 | 0.350 |
Why?
| | Attitude to Health | 1 | 2013 | 406 | 0.350 |
Why?
| | Academic Medical Centers | 1 | 2013 | 411 | 0.350 |
Why?
| | Severity of Illness Index | 8 | 2021 | 2538 | 0.340 |
Why?
| | United States Department of Veterans Affairs | 1 | 2013 | 561 | 0.320 |
Why?
| | Self-Assessment | 2 | 2023 | 60 | 0.300 |
Why?
| | Pregnancy | 4 | 2020 | 5518 | 0.300 |
Why?
| | Panic Disorder | 1 | 2007 | 20 | 0.280 |
Why?
| | Community Mental Health Services | 2 | 2018 | 84 | 0.260 |
Why?
| | Adolescent | 10 | 2023 | 17841 | 0.250 |
Why?
| | Longitudinal Studies | 4 | 2022 | 2387 | 0.250 |
Why?
| | Respiration | 1 | 2006 | 180 | 0.240 |
Why?
| | Pandemics | 2 | 2023 | 1317 | 0.230 |
Why?
| | Alcohol-Related Disorders | 1 | 2006 | 113 | 0.230 |
Why?
| | Psychotherapy, Group | 2 | 2015 | 61 | 0.220 |
Why?
| | Phobic Disorders | 2 | 2014 | 25 | 0.220 |
Why?
| | Saliva | 2 | 2016 | 187 | 0.220 |
Why?
| | Psychiatric Status Rating Scales | 2 | 2018 | 482 | 0.220 |
Why?
| | Patient Dropouts | 2 | 2017 | 66 | 0.220 |
Why?
| | Cognition | 3 | 2023 | 989 | 0.210 |
Why?
| | Death | 1 | 2023 | 107 | 0.210 |
Why?
| | Depressive Disorder, Major | 1 | 2006 | 301 | 0.200 |
Why?
| | Models, Psychological | 2 | 2017 | 297 | 0.190 |
Why?
| | Reward | 1 | 2023 | 211 | 0.190 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 2022 | 138 | 0.190 |
Why?
| | Catastrophization | 1 | 2021 | 8 | 0.190 |
Why?
| | Relaxation Therapy | 2 | 2012 | 15 | 0.190 |
Why?
| | Amoxicillin-Potassium Clavulanate Combination | 1 | 2000 | 8 | 0.180 |
Why?
| | Cephalosporins | 1 | 2000 | 26 | 0.180 |
Why?
| | Cholecystectomy | 1 | 2000 | 45 | 0.180 |
Why?
| | Ecological Momentary Assessment | 1 | 2020 | 22 | 0.180 |
Why?
| | Affective Symptoms | 1 | 2020 | 47 | 0.180 |
Why?
| | Antibiotic Prophylaxis | 1 | 2000 | 96 | 0.170 |
Why?
| | Palliative Care | 2 | 2022 | 642 | 0.160 |
Why?
| | Factor Analysis, Statistical | 1 | 2020 | 257 | 0.160 |
Why?
| | Pharmaceutical Services | 1 | 2020 | 77 | 0.160 |
Why?
| | Community Health Services | 1 | 2021 | 212 | 0.160 |
Why?
| | Clinical Competence | 2 | 2018 | 893 | 0.160 |
Why?
| | Medical Oncology | 1 | 2021 | 229 | 0.160 |
Why?
| | Case-Control Studies | 3 | 2017 | 3003 | 0.160 |
Why?
| | Pregnant Women | 1 | 2020 | 131 | 0.160 |
Why?
| | Thinking | 1 | 2019 | 53 | 0.160 |
Why?
| | Surgical Wound Infection | 1 | 2000 | 248 | 0.150 |
Why?
| | United States | 4 | 2016 | 12181 | 0.150 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2023 | 858 | 0.150 |
Why?
| | Comorbidity | 2 | 2020 | 1448 | 0.140 |
Why?
| | Brain | 2 | 2023 | 2371 | 0.140 |
Why?
| | Motivation | 1 | 2021 | 494 | 0.140 |
Why?
| | Adult Children | 1 | 2017 | 21 | 0.140 |
Why?
| | Stakeholder Participation | 1 | 2018 | 73 | 0.140 |
Why?
| | Decision Making | 1 | 2023 | 782 | 0.140 |
Why?
| | Reference Values | 3 | 2012 | 743 | 0.140 |
Why?
| | Child of Impaired Parents | 1 | 2017 | 40 | 0.140 |
Why?
| | Metaphor | 1 | 2016 | 5 | 0.140 |
Why?
| | Mental Health | 1 | 2022 | 562 | 0.130 |
Why?
| | Pleasure | 1 | 2016 | 18 | 0.130 |
Why?
| | Delivery of Health Care | 1 | 2022 | 833 | 0.130 |
Why?
| | Marketing of Health Services | 1 | 2015 | 12 | 0.130 |
Why?
| | Terminology as Topic | 1 | 2016 | 187 | 0.120 |
Why?
| | Feeding and Eating Disorders | 1 | 2016 | 103 | 0.120 |
Why?
| | Counseling | 1 | 2017 | 342 | 0.120 |
Why?
| | Interviews as Topic | 3 | 2018 | 582 | 0.120 |
Why?
| | Social Alienation | 1 | 2014 | 2 | 0.120 |
Why?
| | Social Behavior | 1 | 2017 | 267 | 0.120 |
Why?
| | Food | 1 | 2016 | 160 | 0.120 |
Why?
| | Forecasting | 1 | 2016 | 330 | 0.120 |
Why?
| | Energy Intake | 2 | 2016 | 427 | 0.110 |
Why?
| | Hydrocortisone | 1 | 2016 | 267 | 0.110 |
Why?
| | Research | 1 | 2016 | 394 | 0.110 |
Why?
| | Panic | 1 | 2012 | 10 | 0.100 |
Why?
| | Ethics Committees, Research | 1 | 2013 | 38 | 0.100 |
Why?
| | Follow-Up Studies | 4 | 2015 | 4411 | 0.100 |
Why?
| | Psychometrics | 1 | 2016 | 608 | 0.100 |
Why?
| | Community-Institutional Relations | 1 | 2013 | 89 | 0.100 |
Why?
| | Evidence-Based Medicine | 2 | 2015 | 668 | 0.100 |
Why?
| | Reproducibility of Results | 2 | 2016 | 2763 | 0.100 |
Why?
| | Internet | 1 | 2016 | 596 | 0.100 |
Why?
| | Aged, 80 and over | 2 | 2020 | 6345 | 0.090 |
Why?
| | Observer Variation | 1 | 2012 | 295 | 0.090 |
Why?
| | Weight Loss | 1 | 2016 | 642 | 0.090 |
Why?
| | Prospective Studies | 2 | 2019 | 6219 | 0.090 |
Why?
| | Lung Neoplasms | 1 | 2023 | 2177 | 0.090 |
Why?
| | Self Report | 4 | 2016 | 696 | 0.090 |
Why?
| | Cooperative Behavior | 1 | 2013 | 381 | 0.090 |
Why?
| | Linear Models | 1 | 2012 | 768 | 0.090 |
Why?
| | Biofeedback, Psychology | 1 | 2010 | 25 | 0.080 |
Why?
| | Desensitization, Psychologic | 1 | 2009 | 2 | 0.080 |
Why?
| | Risk | 1 | 2012 | 812 | 0.080 |
Why?
| | Patient Selection | 1 | 2013 | 641 | 0.080 |
Why?
| | Treatment Refusal | 1 | 2009 | 85 | 0.080 |
Why?
| | Socioeconomic Factors | 1 | 2012 | 1078 | 0.080 |
Why?
| | Analysis of Variance | 2 | 2014 | 1226 | 0.080 |
Why?
| | Patient Education as Topic | 1 | 2012 | 680 | 0.070 |
Why?
| | Obesity | 2 | 2016 | 2508 | 0.070 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2015 | 758 | 0.070 |
Why?
| | Antidepressive Agents, Tricyclic | 1 | 2007 | 29 | 0.070 |
Why?
| | Health Services Accessibility | 3 | 2018 | 762 | 0.070 |
Why?
| | Volition | 1 | 2006 | 31 | 0.070 |
Why?
| | Benzodiazepines | 1 | 2007 | 116 | 0.070 |
Why?
| | Breathing Exercises | 1 | 2006 | 18 | 0.070 |
Why?
| | Patient Compliance | 1 | 2009 | 525 | 0.060 |
Why?
| | Qualitative Research | 2 | 2020 | 934 | 0.060 |
Why?
| | Clinical Trials as Topic | 1 | 2009 | 931 | 0.060 |
Why?
| | Visual Perception | 1 | 2006 | 139 | 0.060 |
Why?
| | Combined Modality Therapy | 1 | 2007 | 1121 | 0.060 |
Why?
| | Telephone | 1 | 2023 | 152 | 0.050 |
Why?
| | Muscles | 1 | 2023 | 320 | 0.050 |
Why?
| | Veterans | 1 | 2013 | 1249 | 0.050 |
Why?
| | Dyspnea | 1 | 2023 | 211 | 0.050 |
Why?
| | Mental Disorders | 1 | 2009 | 892 | 0.050 |
Why?
| | Gallbladder Diseases | 1 | 2000 | 6 | 0.050 |
Why?
| | Logistic Models | 1 | 2006 | 1841 | 0.050 |
Why?
| | Biliary Tract Diseases | 1 | 2000 | 32 | 0.040 |
Why?
| | Age Factors | 1 | 2007 | 2894 | 0.040 |
Why?
| | Probability | 1 | 2000 | 289 | 0.040 |
Why?
| | Infusions, Intravenous | 1 | 2000 | 371 | 0.040 |
Why?
| | Walking | 1 | 2023 | 422 | 0.040 |
Why?
| | Predictive Value of Tests | 2 | 2014 | 1796 | 0.040 |
Why?
| | Administration, Oral | 1 | 2000 | 728 | 0.040 |
Why?
| | Community Mental Health Centers | 1 | 2018 | 13 | 0.040 |
Why?
| | Los Angeles | 1 | 2018 | 56 | 0.040 |
Why?
| | Cost-Benefit Analysis | 1 | 2000 | 544 | 0.040 |
Why?
| | Cerebral Ventricles | 1 | 1997 | 47 | 0.040 |
Why?
| | Caregivers | 1 | 2023 | 717 | 0.030 |
Why?
| | Community-Based Participatory Research | 1 | 2018 | 130 | 0.030 |
Why?
| | Family Relations | 1 | 2017 | 85 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2000 | 1692 | 0.030 |
Why?
| | Focus Groups | 1 | 2018 | 383 | 0.030 |
Why?
| | Primary Health Care | 1 | 2006 | 1512 | 0.030 |
Why?
| | Risk Factors | 2 | 2017 | 8632 | 0.030 |
Why?
| | Meta-Analysis as Topic | 1 | 2016 | 158 | 0.030 |
Why?
| | Personal Satisfaction | 1 | 2017 | 182 | 0.030 |
Why?
| | Task Performance and Analysis | 1 | 2015 | 159 | 0.030 |
Why?
| | Incidence | 1 | 2000 | 2313 | 0.030 |
Why?
| | Marital Status | 1 | 2014 | 41 | 0.030 |
Why?
| | Personality | 1 | 2014 | 113 | 0.030 |
Why?
| | Survival Rate | 1 | 2017 | 1644 | 0.030 |
Why?
| | Waiting Lists | 1 | 2014 | 211 | 0.030 |
Why?
| | Educational Status | 1 | 2014 | 412 | 0.030 |
Why?
| | Proteins | 1 | 1997 | 908 | 0.020 |
Why?
| | Pulmonary Ventilation | 1 | 2012 | 72 | 0.020 |
Why?
| | Precision Medicine | 1 | 2015 | 337 | 0.020 |
Why?
| | Electrocardiography | 1 | 2014 | 560 | 0.020 |
Why?
| | Lung | 1 | 2023 | 3559 | 0.020 |
Why?
| | Child | 2 | 2020 | 18412 | 0.020 |
Why?
| | Parents | 1 | 2017 | 1186 | 0.020 |
Why?
| | Brain Mapping | 1 | 2012 | 524 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2016 | 4408 | 0.020 |
Why?
| | Injections, Intraventricular | 1 | 1997 | 71 | 0.010 |
Why?
| | Fatty Acids, Nonesterified | 1 | 1997 | 151 | 0.010 |
Why?
| | Organ Size | 1 | 1997 | 434 | 0.010 |
Why?
| | Rats, Wistar | 1 | 1997 | 368 | 0.010 |
Why?
| | Corticosterone | 1 | 1997 | 211 | 0.010 |
Why?
| | Leptin | 1 | 1997 | 210 | 0.010 |
Why?
| | Triglycerides | 1 | 1997 | 467 | 0.010 |
Why?
| | Adipose Tissue | 1 | 1997 | 539 | 0.010 |
Why?
| | Body Weight | 1 | 1997 | 870 | 0.010 |
Why?
| | Diet | 1 | 1997 | 1080 | 0.010 |
Why?
| | Rats | 1 | 1997 | 4958 | 0.010 |
Why?
| | Blood Glucose | 1 | 1997 | 1826 | 0.000 |
Why?
| | Insulin | 1 | 1997 | 2078 | 0.000 |
Why?
| | Animals | 1 | 1997 | 31699 | 0.000 |
Why?
|
|
Arch's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|